カテゴリー： Market Monitor Global, 世界, 医療/バイオ

皮膚科処方薬の世界市場見通し2023年-2029年

◆英語タイトル：Prescription Dermatological Medications Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8594 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：71 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Prescription Dermatological Medications Market 調査レポートは次の情報を含め、グローバルにおけるの皮膚科処方薬市場規模と予測を収録しています。・世界の皮膚科処方薬市場：売上、2018年-2023年、2024年-2029年
・世界の皮膚科処方薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の皮膚科処方薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

皮膚科処方薬のグローバル主要企業は、Mylan Pharmaceuticals、 Pfizer、 Almirall、 Bausch Health、 Barrier Therapeutics、 PharmaDerm、 Bristol-Myers Squibb、 Galderma、 Novartisなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、皮膚科処方薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の皮膚科処方薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の皮膚科処方薬市場：タイプ別市場シェア、2022年
・経口、局所

世界の皮膚科処方薬市場：用途別、2018年-2023年、2024年-2029年
世界の皮膚科処方薬市場：用途別市場シェア、2022年
・病院薬局、オンライン薬局、小売薬局

世界の皮膚科処方薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の皮膚科処方薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における皮膚科処方薬のグローバル売上、2018年-2023年
・主要企業における皮膚科処方薬のグローバル売上シェア、2022年
・主要企業における皮膚科処方薬のグローバル販売量、2018年-2023年
・主要企業における皮膚科処方薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Mylan Pharmaceuticals、 Pfizer、 Almirall、 Bausch Health、 Barrier Therapeutics、 PharmaDerm、 Bristol-Myers Squibb、 Galderma、 Novartis

*************************************************************

・調査・分析レポートの概要
皮膚科処方薬市場の定義
市場セグメント
世界の皮膚科処方薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の皮膚科処方薬市場規模
世界の皮膚科処方薬市場規模：2022年 VS 2029年
世界の皮膚科処方薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの皮膚科処方薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の皮膚科処方薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口、局所
皮膚科処方薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、オンライン薬局、小売薬局
皮膚科処方薬の用途別グローバル売上・予測

・地域別市場分析
地域別皮膚科処方薬市場規模 2022年と2029年
地域別皮膚科処方薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Mylan Pharmaceuticals、 Pfizer、 Almirall、 Bausch Health、 Barrier Therapeutics、 PharmaDerm、 Bristol-Myers Squibb、 Galderma、 Novartis
...

Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications.
This report aims to provide a comprehensive presentation of the global market for Prescription Dermatological Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Dermatological Medications. This report contains market size and forecasts of Prescription Dermatological Medications in global, including the following market information:
Global Prescription Dermatological Medications Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Prescription Dermatological Medications Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Prescription Dermatological Medications companies in 2022 (%)
The global Prescription Dermatological Medications market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prescription Dermatological Medications include Mylan Pharmaceuticals, Pfizer, Almirall, Bausch Health, Barrier Therapeutics, PharmaDerm, Bristol-Myers Squibb, Galderma and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prescription Dermatological Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prescription Dermatological Medications Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Dermatological Medications Market Segment Percentages, by Type, 2022 (%)
Oral
Topical
Global Prescription Dermatological Medications Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Dermatological Medications Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Global Prescription Dermatological Medications Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Dermatological Medications Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prescription Dermatological Medications revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Prescription Dermatological Medications revenues share in global market, 2022 (%)
Key companies Prescription Dermatological Medications sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Prescription Dermatological Medications sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan Pharmaceuticals
Pfizer
Almirall
Bausch Health
Barrier Therapeutics
PharmaDerm
Bristol-Myers Squibb
Galderma
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prescription Dermatological Medications, market overview.
Chapter 2: Global Prescription Dermatological Medications market size in revenue and volume.
Chapter 3: Detailed analysis of Prescription Dermatological Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prescription Dermatological Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Prescription Dermatological Medications capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Prescription Dermatological Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prescription Dermatological Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prescription Dermatological Medications Overall Market Size
2.1 Global Prescription Dermatological Medications Market Size: 2022 VS 2029
2.2 Global Prescription Dermatological Medications Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Prescription Dermatological Medications Sales: 2018-2029
3 Company Landscape
3.1 Top Prescription Dermatological Medications Players in Global Market
3.2 Top Global Prescription Dermatological Medications Companies Ranked by Revenue
3.3 Global Prescription Dermatological Medications Revenue by Companies
3.4 Global Prescription Dermatological Medications Sales by Companies
3.5 Global Prescription Dermatological Medications Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Prescription Dermatological Medications Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Prescription Dermatological Medications Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prescription Dermatological Medications Players in Global Market
3.8.1 List of Global Tier 1 Prescription Dermatological Medications Companies
3.8.2 List of Global Tier 2 and Tier 3 Prescription Dermatological Medications Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Prescription Dermatological Medications Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Topical
4.2 By Type – Global Prescription Dermatological Medications Revenue & Forecasts
4.2.1 By Type – Global Prescription Dermatological Medications Revenue, 2018-2023
4.2.2 By Type – Global Prescription Dermatological Medications Revenue, 2024-2029
4.2.3 By Type – Global Prescription Dermatological Medications Revenue Market Share, 2018-2029
4.3 By Type – Global Prescription Dermatological Medications Sales & Forecasts
4.3.1 By Type – Global Prescription Dermatological Medications Sales, 2018-2023
4.3.2 By Type – Global Prescription Dermatological Medications Sales, 2024-2029
4.3.3 By Type – Global Prescription Dermatological Medications Sales Market Share, 2018-2029
4.4 By Type – Global Prescription Dermatological Medications Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Prescription Dermatological Medications Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Retail Pharmacies
5.2 By Application – Global Prescription Dermatological Medications Revenue & Forecasts
5.2.1 By Application – Global Prescription Dermatological Medications Revenue, 2018-2023
5.2.2 By Application – Global Prescription Dermatological Medications Revenue, 2024-2029
5.2.3 By Application – Global Prescription Dermatological Medications Revenue Market Share, 2018-2029
5.3 By Application – Global Prescription Dermatological Medications Sales & Forecasts
5.3.1 By Application – Global Prescription Dermatological Medications Sales, 2018-2023
5.3.2 By Application – Global Prescription Dermatological Medications Sales, 2024-2029
5.3.3 By Application – Global Prescription Dermatological Medications Sales Market Share, 2018-2029
5.4 By Application – Global Prescription Dermatological Medications Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Prescription Dermatological Medications Market Size, 2022 & 2029
6.2 By Region – Global Prescription Dermatological Medications Revenue & Forecasts
6.2.1 By Region – Global Prescription Dermatological Medications Revenue, 2018-2023
6.2.2 By Region – Global Prescription Dermatological Medications Revenue, 2024-2029
6.2.3 By Region – Global Prescription Dermatological Medications Revenue Market Share, 2018-2029
6.3 By Region – Global Prescription Dermatological Medications Sales & Forecasts
6.3.1 By Region – Global Prescription Dermatological Medications Sales, 2018-2023
6.3.2 By Region – Global Prescription Dermatological Medications Sales, 2024-2029
6.3.3 By Region – Global Prescription Dermatological Medications Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Prescription Dermatological Medications Revenue, 2018-2029
6.4.2 By Country – North America Prescription Dermatological Medications Sales, 2018-2029
6.4.3 US Prescription Dermatological Medications Market Size, 2018-2029
6.4.4 Canada Prescription Dermatological Medications Market Size, 2018-2029
6.4.5 Mexico Prescription Dermatological Medications Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Prescription Dermatological Medications Revenue, 2018-2029
6.5.2 By Country – Europe Prescription Dermatological Medications Sales, 2018-2029
6.5.3 Germany Prescription Dermatological Medications Market Size, 2018-2029
6.5.4 France Prescription Dermatological Medications Market Size, 2018-2029
6.5.5 U.K. Prescription Dermatological Medications Market Size, 2018-2029
6.5.6 Italy Prescription Dermatological Medications Market Size, 2018-2029
6.5.7 Russia Prescription Dermatological Medications Market Size, 2018-2029
6.5.8 Nordic Countries Prescription Dermatological Medications Market Size, 2018-2029
6.5.9 Benelux Prescription Dermatological Medications Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Prescription Dermatological Medications Revenue, 2018-2029
6.6.2 By Region – Asia Prescription Dermatological Medications Sales, 2018-2029
6.6.3 China Prescription Dermatological Medications Market Size, 2018-2029
6.6.4 Japan Prescription Dermatological Medications Market Size, 2018-2029
6.6.5 South Korea Prescription Dermatological Medications Market Size, 2018-2029
6.6.6 Southeast Asia Prescription Dermatological Medications Market Size, 2018-2029
6.6.7 India Prescription Dermatological Medications Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Prescription Dermatological Medications Revenue, 2018-2029
6.7.2 By Country – South America Prescription Dermatological Medications Sales, 2018-2029
6.7.3 Brazil Prescription Dermatological Medications Market Size, 2018-2029
6.7.4 Argentina Prescription Dermatological Medications Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Prescription Dermatological Medications Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Prescription Dermatological Medications Sales, 2018-2029
6.8.3 Turkey Prescription Dermatological Medications Market Size, 2018-2029
6.8.4 Israel Prescription Dermatological Medications Market Size, 2018-2029
6.8.5 Saudi Arabia Prescription Dermatological Medications Market Size, 2018-2029
6.8.6 UAE Prescription Dermatological Medications Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Mylan Pharmaceuticals
7.1.1 Mylan Pharmaceuticals Company Summary
7.1.2 Mylan Pharmaceuticals Business Overview
7.1.3 Mylan Pharmaceuticals Prescription Dermatological Medications Major Product Offerings
7.1.4 Mylan Pharmaceuticals Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.1.5 Mylan Pharmaceuticals Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Prescription Dermatological Medications Major Product Offerings
7.2.4 Pfizer Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Almirall
7.3.1 Almirall Company Summary
7.3.2 Almirall Business Overview
7.3.3 Almirall Prescription Dermatological Medications Major Product Offerings
7.3.4 Almirall Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.3.5 Almirall Key News & Latest Developments
7.4 Bausch Health
7.4.1 Bausch Health Company Summary
7.4.2 Bausch Health Business Overview
7.4.3 Bausch Health Prescription Dermatological Medications Major Product Offerings
7.4.4 Bausch Health Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.4.5 Bausch Health Key News & Latest Developments
7.5 Barrier Therapeutics
7.5.1 Barrier Therapeutics Company Summary
7.5.2 Barrier Therapeutics Business Overview
7.5.3 Barrier Therapeutics Prescription Dermatological Medications Major Product Offerings
7.5.4 Barrier Therapeutics Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.5.5 Barrier Therapeutics Key News & Latest Developments
7.6 PharmaDerm
7.6.1 PharmaDerm Company Summary
7.6.2 PharmaDerm Business Overview
7.6.3 PharmaDerm Prescription Dermatological Medications Major Product Offerings
7.6.4 PharmaDerm Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.6.5 PharmaDerm Key News & Latest Developments
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Company Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Prescription Dermatological Medications Major Product Offerings
7.7.4 Bristol-Myers Squibb Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.7.5 Bristol-Myers Squibb Key News & Latest Developments
7.8 Galderma
7.8.1 Galderma Company Summary
7.8.2 Galderma Business Overview
7.8.3 Galderma Prescription Dermatological Medications Major Product Offerings
7.8.4 Galderma Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.8.5 Galderma Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Prescription Dermatological Medications Major Product Offerings
7.9.4 Novartis Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.9.5 Novartis Key News & Latest Developments
8 Global Prescription Dermatological Medications Production Capacity, Analysis
8.1 Global Prescription Dermatological Medications Production Capacity, 2018-2029
8.2 Prescription Dermatological Medications Production Capacity of Key Manufacturers in Global Market
8.3 Global Prescription Dermatological Medications Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prescription Dermatological Medications Supply Chain Analysis
10.1 Prescription Dermatological Medications Industry Value Chain
10.2 Prescription Dermatological Medications Upstream Market
10.3 Prescription Dermatological Medications Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prescription Dermatological Medications Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Prescription Dermatological Medications in Global Market
Table 2. Top Prescription Dermatological Medications Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Prescription Dermatological Medications Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Prescription Dermatological Medications Revenue Share by Companies, 2018-2023
Table 5. Global Prescription Dermatological Medications Sales by Companies, (K Units), 2018-2023
Table 6. Global Prescription Dermatological Medications Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Prescription Dermatological Medications Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Prescription Dermatological Medications Product Type
Table 9. List of Global Tier 1 Prescription Dermatological Medications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prescription Dermatological Medications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Prescription Dermatological Medications Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Prescription Dermatological Medications Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Prescription Dermatological Medications Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Prescription Dermatological Medications Sales (K Units), 2018-2023
Table 15. By Type - Global Prescription Dermatological Medications Sales (K Units), 2024-2029
Table 16. By Application – Global Prescription Dermatological Medications Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Prescription Dermatological Medications Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Prescription Dermatological Medications Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Prescription Dermatological Medications Sales (K Units), 2018-2023
Table 20. By Application - Global Prescription Dermatological Medications Sales (K Units), 2024-2029
Table 21. By Region – Global Prescription Dermatological Medications Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Prescription Dermatological Medications Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Prescription Dermatological Medications Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Prescription Dermatological Medications Sales (K Units), 2018-2023
Table 25. By Region - Global Prescription Dermatological Medications Sales (K Units), 2024-2029
Table 26. By Country - North America Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Prescription Dermatological Medications Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Prescription Dermatological Medications Sales, (K Units), 2018-2023
Table 29. By Country - North America Prescription Dermatological Medications Sales, (K Units), 2024-2029
Table 30. By Country - Europe Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Prescription Dermatological Medications Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Prescription Dermatological Medications Sales, (K Units), 2018-2023
Table 33. By Country - Europe Prescription Dermatological Medications Sales, (K Units), 2024-2029
Table 34. By Region - Asia Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Prescription Dermatological Medications Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Prescription Dermatological Medications Sales, (K Units), 2018-2023
Table 37. By Region - Asia Prescription Dermatological Medications Sales, (K Units), 2024-2029
Table 38. By Country - South America Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Prescription Dermatological Medications Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Prescription Dermatological Medications Sales, (K Units), 2018-2023
Table 41. By Country - South America Prescription Dermatological Medications Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Prescription Dermatological Medications Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Prescription Dermatological Medications Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Prescription Dermatological Medications Sales, (K Units), 2024-2029
Table 46. Mylan Pharmaceuticals Company Summary
Table 47. Mylan Pharmaceuticals Prescription Dermatological Medications Product Offerings
Table 48. Mylan Pharmaceuticals Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Mylan Pharmaceuticals Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Prescription Dermatological Medications Product Offerings
Table 52. Pfizer Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Almirall Company Summary
Table 55. Almirall Prescription Dermatological Medications Product Offerings
Table 56. Almirall Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Almirall Key News & Latest Developments
Table 58. Bausch Health Company Summary
Table 59. Bausch Health Prescription Dermatological Medications Product Offerings
Table 60. Bausch Health Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Bausch Health Key News & Latest Developments
Table 62. Barrier Therapeutics Company Summary
Table 63. Barrier Therapeutics Prescription Dermatological Medications Product Offerings
Table 64. Barrier Therapeutics Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Barrier Therapeutics Key News & Latest Developments
Table 66. PharmaDerm Company Summary
Table 67. PharmaDerm Prescription Dermatological Medications Product Offerings
Table 68. PharmaDerm Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. PharmaDerm Key News & Latest Developments
Table 70. Bristol-Myers Squibb Company Summary
Table 71. Bristol-Myers Squibb Prescription Dermatological Medications Product Offerings
Table 72. Bristol-Myers Squibb Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Bristol-Myers Squibb Key News & Latest Developments
Table 74. Galderma Company Summary
Table 75. Galderma Prescription Dermatological Medications Product Offerings
Table 76. Galderma Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Galderma Key News & Latest Developments
Table 78. Novartis Company Summary
Table 79. Novartis Prescription Dermatological Medications Product Offerings
Table 80. Novartis Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Novartis Key News & Latest Developments
Table 82. Prescription Dermatological Medications Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Prescription Dermatological Medications Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Prescription Dermatological Medications Production by Region, 2018-2023 (K Units)
Table 85. Global Prescription Dermatological Medications Production by Region, 2024-2029 (K Units)
Table 86. Prescription Dermatological Medications Market Opportunities & Trends in Global Market
Table 87. Prescription Dermatological Medications Market Drivers in Global Market
Table 88. Prescription Dermatological Medications Market Restraints in Global Market
Table 89. Prescription Dermatological Medications Raw Materials
Table 90. Prescription Dermatological Medications Raw Materials Suppliers in Global Market
Table 91. Typical Prescription Dermatological Medications Downstream
Table 92. Prescription Dermatological Medications Downstream Clients in Global Market
Table 93. Prescription Dermatological Medications Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Prescription Dermatological Medications Segment by Type in 2022
Figure 2. Prescription Dermatological Medications Segment by Application in 2022
Figure 3. Global Prescription Dermatological Medications Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prescription Dermatological Medications Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prescription Dermatological Medications Revenue, 2018-2029 (US$, Mn)
Figure 7. Prescription Dermatological Medications Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prescription Dermatological Medications Revenue in 2022
Figure 9. By Type - Global Prescription Dermatological Medications Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Prescription Dermatological Medications Revenue Market Share, 2018-2029
Figure 11. By Type - Global Prescription Dermatological Medications Sales Market Share, 2018-2029
Figure 12. By Type - Global Prescription Dermatological Medications Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Prescription Dermatological Medications Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Prescription Dermatological Medications Revenue Market Share, 2018-2029
Figure 15. By Application - Global Prescription Dermatological Medications Sales Market Share, 2018-2029
Figure 16. By Application - Global Prescription Dermatological Medications Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Prescription Dermatological Medications Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Prescription Dermatological Medications Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Prescription Dermatological Medications Revenue Market Share, 2018-2029
Figure 20. By Region - Global Prescription Dermatological Medications Sales Market Share, 2018-2029
Figure 21. By Country - North America Prescription Dermatological Medications Revenue Market Share, 2018-2029
Figure 22. By Country - North America Prescription Dermatological Medications Sales Market Share, 2018-2029
Figure 23. US Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Prescription Dermatological Medications Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Prescription Dermatological Medications Sales Market Share, 2018-2029
Figure 28. Germany Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 29. France Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Prescription Dermatological Medications Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Prescription Dermatological Medications Sales Market Share, 2018-2029
Figure 37. China Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 41. India Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Prescription Dermatological Medications Revenue Market Share, 2018-2029
Figure 43. By Country - South America Prescription Dermatological Medications Sales Market Share, 2018-2029
Figure 44. Brazil Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Prescription Dermatological Medications Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Prescription Dermatological Medications Sales Market Share, 2018-2029
Figure 48. Turkey Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Prescription Dermatological Medications Revenue, (US$, Mn), 2018-2029
Figure 52. Global Prescription Dermatological Medications Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Prescription Dermatological Medications by Region, 2022 VS 2029
Figure 54. Prescription Dermatological Medications Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 皮膚科処方薬の世界市場見通し2023年-2029年(Prescription Dermatological Medications Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

皮膚科処方薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp